Ποια είναι η τιμή για Greenyn Biotechnology Co., Ltd (6846)

Η τιμή για Greenyn Biotechnology Co., Ltd (6846) είναι $1.82

Ποια είναι η κεφαλαιοποίηση αγοράς για Greenyn Biotechnology Co., Ltd (6846)

Η κεφαλαιοποίηση αγοράς για Greenyn Biotechnology Co., Ltd (6846) είναι $49.23M

Greenyn Biotechnology Co., Ltd (6846) Τιμή και Κεφαλαιοποίηση Αγοράς

Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.

Η τιμή για 6846	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$194,222 $49.23M	NVDA	$5.257T	+10,677,850.28%
$169,904 $49.23M	AAPL	$4.599T	+9,340,886.37%
$151,723 $49.23M	GOOG	$4.107T	+8,341,374.22%
$132,167 $49.23M	MSFT	$3.577T	+7,266,176.03%
$103,720 $49.23M	AMZN	$2.807T	+5,702,223.35%

Η τιμή για 6846

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$194,222 $49.23M